Detection of papillary thyroid carcinoma with serum protein profile analysis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 2, 2008, Pages 198-202

  Moretz III, William H ^a   Gourin, Christine G ^a   Terris, David J ^a   Xia, Zhong Sheng ^a   Liu, Zhongmin ^a   Weinberger, Paul M ^a   Chin, Edward ^a   Adam, Bao Ling ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; BENIGN TUMOR; BLOOD SAMPLING; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 39649107938     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2007.34     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2007;57(1):43-66.
2. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules. Am J Med. 1992;93(4):363-369.
3. Griffith OL, Melck A, Jones SJ, Wiseman SM. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. J Clin Oncol. 2006;24(31):5043-5051.
4. Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006;16(1):55-60.
5. Mazzaferri EL, Robbins RJ, Spencer CA, et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88(4):1433-1441.
6. Gourin CG, Xia ZS, Han Y, et al. Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132(4):390-397.
7. Wadsworth JT, Somers KD, Stack BC Jr, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg. 2004;130(1):98-104.
8. Kohavi R. A study of cross-validation and bootstrap for accuracy estimation and model selection. In: Wermter S, Riloff E, Scheler G, eds. The Fourteenth International Joint Conference on Artificial Intelligence (IJCAI). San Francisco, CA: Morgan Kaufman; 1995:1137-1145.
9. Liotta LA, Petricoin EF. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J Clin Invest. 2006;116(1):26-30.
10. Adam BL, Viahou A, Semmes OJ, Wright GL Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics. 2001;1(10):1264-1270.
11. Petricoin EF III, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 2002;94(20):1576-1578.
12. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359(9306):572-577.
13. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res. 2002;62(13):3609-3614.
14. Diamandis EP. Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? Clin Chem. 2003;49(8):1272-1278.
15. Ito Y, Yoshida H, Tomoda C, et al. S100A4 expression is an early event of papillary carcinoma of the thyroid. Oncology. 2004;67(5-6):397-402.
16. Shi Y, Zou M, Collison K, et al. RNA interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model. J Clin Endocrinol Metab. 2006;91(6):2373-2379.
17. Zou M, Al-Baradie RS, Al-Hindi H, Farid NR, Shi Y. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer. 2005;93(11):1277-1284.
18. Watanabe Y, Kobayashi R, Ishikawa T, Hidaka H. Isolation and characterization of a calcium-binding protein derived from mRNA termed p9Ka, pEL-98, 18A2, or 42A by the newly synthesized vasorelaxant W-66 affinity chromatography. Arch Biochem Biophys. 1992;292(2):563-569.
19. Schmidt-Hansen B, Klingelhofer J, Grum-Schwensen B, Christensen A, Andresen S. Functional significance of metastasis-inducing S100A4 (Mts1) in tumorstroma interplay. J Biol Chem. 2004;279(23):24498-24504.
20. Economos K, MacDonald PC, Casey ML. Endothelin-1 gene expression and biosynthesis in human endometrial HEC-1A cancer cells. Cancer Res. 1992;52(3):554-557.
21. Donckier JE, Michel L, Van Beneden R, Delos M, Havaux X. Increased expression of endothelin-1 and its mitogenic receptor ETA in human papillary thyroid carcinoma. Clin Endocrinol (Oxf ). 2003;59(3):354-360.
22. Boldrini L, Gisfredi S, Ursino S, et al. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma. Eur J Cancer. 2005;41(18):2828-2835.
23. Cheng AJ, Chen LC, Chien KY, et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem. 2005;51(12):2236-2244.
24. Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest. 2006;116(1):271-284.